L
Lam Dong Pharmaceutical JSC
VN:LDP
Lam Dong Pharmaceutical JSC
VN:LDP
Price:
8 000
VND
-1.23%
Market Closed
Market Cap:
₫149.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lam Dong Pharmaceutical JSC
VN:LDP
|
VN |
|
S
|
Solid FAB
STO:SFAB
|
SE |
|
B
|
Barloworld Ltd
JSE:BAW
|
ZA |
|
Q
|
Qumu Corp
F:RMG
|
US |
|
Aoyama Zaisan Networks Co Ltd
TSE:8929
|
JP |
|
Vitesco Technologies Group AG
XETRA:VTSC
|
DE |
|
Mackenzie Realty Capital Inc
OTC:MKZR
|
US |
|
A
|
American Coastal Insurance Corp
NASDAQ:ACIC
|
US |
|
Ina Invest Holding AG
SIX:INA
|
CH |
|
M
|
Myriad Uranium Corp
OTC:MYRUF
|
CA |
|
Sagami Holdings Corp
TSE:9900
|
JP |
|
K
|
Krakatau Steel (Persero) Tbk PT
IDX:KRAS
|
ID |
Multiples-Based Value
The Multiples-Based Value of one LDP stock under the Base Case scenario is hidden VND. Compared to the current market price of 8 000 VND, Lam Dong Pharmaceutical JSC is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LDP Multiples-Based Value
LOCKED
Multiples Across Competitors
LDP Competitors Multiples
Lam Dong Pharmaceutical JSC Competitors
Lam Dong Pharmaceutical JSC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| VN |
L
|
Lam Dong Pharmaceutical JSC
VN:LDP
|
149.8B VND | 0.6 | 5.5 | 7.3 | 9.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.9 | 43.9 | 29.6 | 31.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.5 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD | 2.5 | 16.8 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
